FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileZeroStack Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZSTK
ZeroStack Corp. Stock AnalysisComprehensive stock analysis for ZeroStack Corp. (ZSTK) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisZSTK
ZSTK
ZeroStack Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZSTK
Home🔹Stocks🔹ZeroStack Corp.

ZeroStack Corp.

🇺🇸ZSTK•NASDAQ

ZeroStack Corp.

🇺🇸ZSTK•NASDAQ
Market cap
$58.63M
Sentiment

Your view on ZSTK

Mkt Cap
$58.63M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ZeroStack Corp.

Industry
Asset Management
Sector
Financial Services
CEO
Daniel Reis-Faria
Headquarters
40 King Street West, Toronto, ON, CA
Industry
Asset Management
Sector
Financial Services
CEO
Daniel Reis-Faria
Headquarters
40 King Street West, Toronto, ON, CA
Description

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments.

The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.

It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies.

The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for ZeroStack Corp. from FRC's valuation model, read against the market price. ZSTK last traded at $2.69; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for ZeroStack Corp.. Starting points for ZeroStack Corp.: EPS -$17.85, beta 1.71 — an Asset Management name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for ZeroStack Corp.. ZeroStack Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for ZeroStack Corp.. Trailing twelve-month EPS for ZeroStack Corp. stands at -$17.85. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for ZeroStack Corp.. ZeroStack Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

ZeroStack Corp. valued side by side against its closest peers. ZeroStack Corp. is measured against Asset Management peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold ZeroStack Corp., and how their positions are changing. At a $58.6M market value, institutional positions materially move ZeroStack Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by ZeroStack Corp. executives and directors. Shares of ZeroStack Corp. have traded between $1.32 and $15.04 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming ZeroStack Corp.. ZeroStack Corp. is a $58.6M Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming ZeroStack Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for ZeroStack Corp.. Coverage tracks ZeroStack Corp. within Asset Management (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of ZeroStack Corp.

Peer companies

  • AIMAIM ImmunoTech Inc.
  • AKANAkanda Corp.
  • AMIXAutonomix Medical, Inc. Common Stock
  • CPHIChina Pharma Holdings, Inc.
  • ENSCEnsysce Biosciences, Inc.
  • KALAKALA BIO, Inc.
  • KZIAKazia Therapeutics Limited

More Asset Management companies

  • TRRPFTorrent Capital Ltd.
  • TSLXSixth Street Specialty Lending, Inc.
  • TSRUFPacific Current Group Limited
  • TUXSTuxis Corporation
  • TVL.AXTouch Ventures Limited
  • TWAVTaoWeave, Inc.
  • TY-PTri-Continental Corporation PFD $2.50
  • UBAAFUrbana Corporation
  • URB-A.CNUrbana Corporation
  • URB-A.TOUrbana Corporation
  • URB.CNUrbana Corporation
  • URB.TOUrbana Corporation

ETFs holding ZeroStack Corp.

Largest holders, then the funds most concentrated in ZSTK · % = share of the fund

  • VXFVanguard Extended Market ETF0.00%
  • VTIVanguard Total Stock Market ETF
  • VUN.TOVanguard U.S. Total Market Index ETF
  • VEQT.TOVanguard All-Equity ETF Portfolio
  • VGRO.TOVanguard Growth ETF Portfolio
  • VBAL.TOVanguard Balanced ETF Portfolio
  • VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)
  • VCNS.TOVanguard Conservative ETF Portfolio
ZSTK Analysis
Weak
Past1
Growth1
Health4
Profit1
Value1

News

Latest Market News